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Presenilin
STIM1
STIM2S1), which are the major cause of familial Alzheimer's disease (FAD), are involved
in perturbations of cellular Ca2+ homeostasis. Attenuation of capacitative Ca2+ entry (CCE) is the most often
observed alteration of Ca2+ homeostasis in cells bearing FAD PS1 mutations. However, molecular
mechanisms underlying this CCE impairment remains elusive. We demonstrate that cellular levels of STIM1
and STIM2 proteins, which are key players in CCE, depend on presenilins. We found increased level of STIM1
and decreased level of STIM2 proteins in mouse embryonic ﬁbroblasts lacking presenilins. Fura-2 ratiometric
assays revealed that CCE is enhanced in these cells after Ca2+ stores depletion by thapsigargin treatment. In
turn, overexpression of PS1 with FAD mutations in HEK293 cells led to an attenuation of CCE. Although, no
changes in STIM protein levels were observed in these HEK293 cells, FAD mutations in endogenous PS1 in
human B lymphocytes resulted in a decreased expression of STIM2 in parallel to an attenuation of CCE. Our
experiments showing that knock-out of presenilins in MEF cells and FAD mutations in endogenous PS1 in
lymphocytes affect both CCE and the cellular level of STIM proteins open new perspectives for studies on CCE
in FAD.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Alzheimer's disease (AD) is a chronic disorder that leads to the
death of neurons and causes severe cognitive disability and dementia.
Mutations in presenilin1 (PS1), presenilin2 (PS2) and amyloid
precursor protein (APP) lead to familial Alzheimer's disease (FAD),
reviewed in [1]. The neuropathological hallmarks of AD include a
progressive loss of neurons, synaptic degeneration, as well as a
deposition of β-amyloid (Aβ) plaques and of neuroﬁbrillary tangles in
speciﬁc brain regions. Additionally, disturbances in Ca2+ homeostasis
have been demonstrated as one of the early pathological changes in
cells of AD patients [2,3], reviewed in [4] and [5].
Endoplasmic reticulum (ER) is the main Ca2+ store in the cell.
After cell activation, Ca2+ is released from ER in a pattern speciﬁc for
time, space and dynamics [6]. The Ca2+ release results in a depletion
of ER Ca2+ stores, which have to be replenished by inﬂux of Ca2+ by
store-operated Ca2+ channels (SOCs) [7]. This process of Ca2+ inﬂux
via channels activated by the depletion of ER Ca2+ stores, is called
capacitative Ca2+ entry (CCE) [7]. CCE is considered to be ubiquitouslecular and Cell Biology, 4 Ks.
70700; fax: +48225970715.
icki).
ll rights reserved.in non-excitable cells where it has been studied extensively,
reviewed in [7]. There are, however, reports demonstrating that
CCE also occurs in excitable cells, such as smooth muscle cells [8]
and neuronal cells [9,10].
Attenuation of CCE was shown in several cell types expressing
different FAD mutations in PS1 [11–13], reviewed in [5]. This
alteration of Ca2+ homeostasis may contribute to AD pathogenesis,
as the PS1 mutation-driven inhibition of CCE was shown to
inﬂuence APP processing leading to an increased generation of
neurotoxic Aβ1-42 [12].
To date, the molecular mechanism underlying FAD-related
disturbances in CCE has not been clariﬁed. However, the recent
discovery that STIM1 and STIM2 (Stromal Interacting Molecules 1 and
2) are regulators of CCE, shed a new light on this issue [14,15]. STIM1
and STIM2 are type I ER membrane proteins, containing an unpaired
EF-hand motifs that act as Ca2+ sensors in the ER lumen. These
proteins transduce information on the ER Ca2+ level to the plasma
membrane. Upon ER Ca2+ store depletion, STIM1 and STIM2
redistribute into punctuate structures, move towards the plasma
membrane and activate SOC channels [14,16]. Orai1 (CRACM1) is a
plasma membrane protein that was shown to be a pore-forming
subunit of the SOC channel, activated by STIM1 and STIM2 [17–22].
The aim of our work was to assess whether the expression of STIM
proteins depends on presenilins and, if so, whether STIM1 and STIM2
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show that both cellular levels of STIM proteins and CCE are inﬂuenced
by presenilins, which suggest that STIM1 and STIM2may play a role in
presenilin-dependent alterations of CCE in Alzheimer's disease.
2. Materials and methods
2.1. Cell cultures and antibodies
Human peripheral blood B lymphocytes were isolated from
healthy 65 year-old individuals (control group) and from FAD patients
with identiﬁed mutations in PS1: M139V, H163R, S170F (two
patients), E318G, I213F and P117R. In most of the experiments the
control group consisted of 8 cell lines isolated from 8 individuals. For
the measurements of free intracellular Ca2+, 4 control cell lines were
used. Cells were immortalized with Epstein–Barr virus according to a
previously described protocol [23] and cultured in RPMI 1640medium
in 1% HEPES buffer and 1% penicillin-streptomycin, supplemented
with 10% fetal bovine serum and 2% L-glutamine (all from Sigma).
Experimental procedures were approved by the Ethical Committee at
the Central Clinical Hospital of the Ministry of Internal Affairs and
Administration in Warsaw, Poland. Wild type mouse embryonic
ﬁbroblasts (MEF) and PS1−/−, PS2−/− and double knockout cell
lines (DKO, lacking both PS1 and PS2) were a kind gift of Bart De
Strooper (Catholic University, Leuven, Belgium). MEF as well as
HEK293 cells were cultured in DMEM F12 HAM medium with 1%
penicillin-streptomycin, supplemented with 10% fetal bovine serum.
We used rabbit anti-STIM1 (ProteinTech Group Inc.) and anti-STIM2
(CT) (ProSci Incorporated) polyclonal antibodies as well as mouse
anti-actin monoclonal antibody (Sigma).
2.2. Site directed mutagenesis and generation of HEK293 cell lines stably
transfected with PS1 FAD mutants
To obtain FAD mutants (P117R, S170F, I213F, L226F, E318G) of
human PS1, site directed mutagenesis was performed with PCR in
which Turbo Pfu polymerase (Stratagene) and pcDNA3.1(−)/wtPS1
vector (a kind gift of Dr. Jessie Theuns from The University
of Antwerp, Belgium) were used as a template. PCR was conducted
with the following pairs of primers: P117R F: 5′ GCAGCTAATCTA-
TACCC(C→G)ATTCACA GAAGATACCGA and R: 5′TCGGTATCTTCTGT-
G A A T C G G G T A T A G A T T A G C T G C , S 1 7 0 F F : 5 ′
C→TTCTATTGTTGCTGTTCTTTTTTTCATTCATTTAC and R: 5′ ATG ATA-
TAATAAGCCAGGCATGGATGACC, I213F F: 5′ GGTGGGAATGATTTC
C(A→T)TTCACTGGAAAGGTCC and R: 5′ TGGACCTTTCCAGTGAAAG-
GAAATCA TTCCCACC, L226F F: 5′ CGACTCCAGCAGGCATAT(T→A)
TCATTATGATTAGTG CC and R: 5 ′ GGCACTAATCATATG-
AAATATGCCTGCTGGAGTCG, E318G F: 5′A→GAAGCACAGAAAGGGGTA-
CAAGACAC and R: 5′ CTGCATTATACTTG GAATTTTTGGATACTCTCC.
After the reaction the PCR products were incubated with DpnI
restrictase to eliminate the methylated template. HEK293 cells
were transfected with PEI (New England Biolabs) according to
manufacturer's protocol. Selection of stable transfectants with G418
(Promega) was started after the cells in culture reached 80%
conﬂuency.
2.3. Intracellular Ca2+ measurements
Fura-2 digital ﬂuorescence microscopy was used to determine the
changes in intracellular Ca2+ levels ([Ca2+]i) [24]. Brieﬂy, MEF and
HEK293 cells were plated on poly-L-lysine (Sigma) coated coverslips
the day before, and human B lymphocytes 3 h before the start of the
experiment. 30 min before the Ca2+ measurements, the culture
medium was replaced by 2 µM Fura-2 AM (Molecular Probes) in a
solution containing 137mMNaCl, 2.7 mMKCl, 1 mMNa2HPO4, 25 mM
glucose, 20 mM HEPES (pH 7.4), 1 mM MgCl2, 1% bovine serumalbumin (standard buffer) supplemented with 2 mM CaCl2 at 37 °C.
The coverslips were then mounted in a chamber on a Nikon Diaphot
inverted-stage microscope equipped with a ﬂuo×40/1.3 NA oil-
immersion objective lens. Ludl Lep MAC 5000 ﬁlter wheel system
loaded with a Chroma Fura-2 ﬁlter set was used for illumination of
specimens. Images were acquired using a Retiga 1300 chilled digital
CCD camera (QImaging). Measurements were started in a standard
buffer supplemented with 0.5 mM EGTA, which after 1 min was
replaced by standard buffer supplemented with 0.5 mM EGTA and
1 µM thapsigargin (SIGMA). Afterwards ER Ca2+ stores depletion
medium was replaced by standard buffer supplemented with 2 mM
CaCl2. Data processing was carried out using AQM Advance 6 (Kinetic
Imaging Inc) and the MS Excel software. The number of cells
measured in at least 3 independent experiments ranged from 52 to
149 for each human B cell line, 89–136 cells for each HEK293 cell line
and 125–175 cells for each MEF cell line. Δ [Ca2+] was calculated as a
ratio of the maximum Fura-2 340/380 nm ﬂuorescence intensity after
cell treatment with thapsigargin and CaCl2 re-addition, to the value of
basal Fura-2 340/380 nm ﬂuorescence intensity, averaged for the ﬁrst
minute of the experiment.
2.4. Real time PCR analysis
RNA was isolated from human B lymphocytes or from MEF cells
using the RNeasy Mini Kit (Qiagen). First-strand cDNA (prepared with
SuperScript III, Invitrogen) was examined by quantitative Real time PCR
with one pair of the following gene- and species-speciﬁc primers:
human STIM1 (5′AGGCTCTCAATGCCSTGACTTCCA, 5′GTTCAGCGCCAG-
TAATGCCTTCTT), human STIM2 (5′AGGATAGCAGTGACG AACCTTA, 5′
TTCATCCAGTTATGAGGTGGGCGT), mouse STIM1 (5′GCTCTCA ATGC-
CATGCCTTCCAAT, 5′TCTAGGCCATGGTTCAACGCCATA) and mouse
STIM2 (5′AGCAGTAGTTTATGCCGCTCTCGT, 5′AGGGCAACTTGACACAGA-
CAG GAT), using SYBR Green dye (Applied Biosystems). The samples
were analyzed using 7000 Sequence Detection System hardware and
software (Applied Biosystems). 18S RNA for normalization was used
with the following pair of primers: 5′AACGAACGAGACTC TGGCATG, 5′
CGGACATCTAAGGGCATCACA.
2.5. Immunoblotting
Total protein extracts from B lymphocytes were prepared in a
lysis buffer containing 50 mM Tris pH 7.5, 1% NP-40, 0.5% NaDOC
and Complete EDTA-Free Protease Inhibitors Cocktail (Roche). Cells
were homogenized on ice with a motorized pellet pestle (Sigma)
for 5 min and cleared by centrifugation at 12,000 ×g for 10 min.
Protein extracts were separated on a 10% SDS-PAGE gel and
transferred to Hybond-ECL nitrocellulose membranes (Amersham).
The membranes were then immunostained with the appropriate
antibodies. The intensity of the bands was measured using a GS-
800 Calibrated densitometer and the Quantity One software
(Biorad). As a double band was seen on immunoblots on human
B lymphocytes and HEK293 cells developed with anti-STIM2
antibody (ProSci Incorporated), we analyzed the lower band
which, according to antibody manufacturer information, represents
STIM2 protein.
2.6. Statistical analysis
Statistical signiﬁcance of results of intracellular Ca2+ measure-
ments in human B cells was calculated with non-parametric Mann–
Whitney U test. Statistical signiﬁcance of results of calcium
measurements in MEF and HEK293 cell lines, protein level analysis
in HEK293 and MEF cell lines as well as quantiﬁcation of mRNA for
STIM proteins in MEF cell lines were calculated with analysis of
variance (ANOVA). Normal distribution of results of all other
experiments was indicated with Shapiro–Wilk normality test and
Fig. 1. CCE is enhanced in MEF cells lacking presenilins. (A) Averaged traces obtained by ratiometric Fura-2 analysis of MEF cell lines derived from wt, PS1−/−, PS2−/− or DKO
(lacking both PS1 and PS2) animals. (B) Results of quantiﬁcation of CCE in 4 MEF cell lines (⁎⁎⁎Pb0,001).
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with T-test.
3. Results
3.1. Capacitative Ca2+ entry is enhanced in cells lacking presenilins
To establish the extent of CCE changes caused by a loss of
presenilins, we ﬁrst analyzed wt, PS1−/−, PS2−/− and DKO
(double knock-out, lacking both presenilins) MEF cell lines. Fura-2
assay was used to monitor changes of cytosolic Ca2+ concentrations.
MEF cells were treated with the SERCA pump inhibitor thapsigargin
in Ca2+-depleted medium to empty ER Ca2+ stores. After stores
depletion, the bath solution was replaced by Ca2+ rich buffer in
order to facilitate CCE.
Analysis of Fura-2 340 nm/380 nm ﬂuorescence ratio revealed
enhanced CCE in PS1−/− and DKO cell lines compared to wt
control (Fig. 1). These results conﬁrmed earlier data on the effects
of presenilin loss on CCE [12,25,26] and proved the usefulness ofFig. 2. Cellular level of STIM1 protein is elevated and that of STIM2 is decreased in MEF DKO
with anti-STIM1 and anti-STIM2 antibodies and results of densitometric analysis of ﬁve inde
levels in MEF cell lines derived from wt, PS1−/−, PS2−/− or DKO (lacking both PS1 andMEF cells for further studies on mechanisms of presenilin
dependent CCE alterations.
3.2. Cellular levels of STIM1 and STIM2 are presenilin dependent
To determinewhether the expression of STIM1 and STIM2 proteins
depended on presenilins, we measured the levels of both mRNA and
protein of STIMs in MEF cells lacking PS1 or PS2 or both genes.
Immunoblotting with anti-STIM1 antibody showed elevated level of
STIM1 in MEF DKO cells in comparison to the wt cell line (Fig. 2A,
Supplementary Table 1.). This result correlated with trends observed
in several RT-PCR experiments in which increased level of Stim1
mRNA was detected in MEF DKO cells (Fig. 2B).
In turn, the level of Stim2mRNAwas decreased in MEF DKO cells in
comparison to wt MEF, however this change was not statistically
signiﬁcant (Fig. 2C). Densitometric analysis of immunoblots of protein
extracts obtained from MEF cells, probed with anti-STIM2 antibody,
showed decreased STIM2 protein levels in both DKO and PS1−/− cell
lines (Fig. 2D).cells. (A,D) Representative immunoblots of protein extracts from B cell lines developed
pendent experiments. (B,C) Results of RT-PCR quantiﬁcation of STIM1 and STIM2 mRNA
PS2) animals.
Fig. 3. CCE is attenuated but STIM proteins' levels are not affected by overexpression of PS1 FADmutants in HEK293 cells. (A) Averaged traces obtained by ratiometric Fura-2 analysis
of HEK293 cell lines overexpressing wt PS1 and PS1 P117R and PS1 E318G mutants. (B) Results of quantiﬁcation of CCE in analyzed HEK293 cell lines (⁎⁎⁎Pb0,001).
(C) Representative immunoblot of protein extracts from HEK293 cell lines developed with anti-STIM1 and anti-STIM2 (D) antibodies and results of densitometric analysis of three
independent experiments.
Fig. 4. CCE is attenuated in B cells isolated from FAD patients with PS1 mutations. (A) Averaged traces obtained by ratiometric Fura-2 analysis of B cells isolated from healthy
individual (wtPS1) and FAD patients (P117R and E318G). (B) Results of quantiﬁcation of averaged CCE in cell populations of healthy controls and FAD patients. Each symbol
represents themean value of three independent experiments on each cell line bearing one of analyzed FADmutations in PS1. Horizontal lines represent mean values of results within
a group.
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Fig. 5. STIM2 mRNA and protein levels are decreased in B lymphocytes isolated from FAD patients. (A,C) Results of RT-PCR quantiﬁcation of STIM1 and STIM2 mRNA levels in cell
populations from healthy controls and FAD patients. (B,D) Representative immunoblot of protein extracts from B lymphocytes lines developed with anti-STIM1 and anti-STIM2 (D)
antibodies and results of densitometric analysis of three independent experiments.
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proteins depend on presenilins, and that STIM1 and STIM2 are
differently affected by presenilins' loss. Lack of both PS1 and PS2
results in an increased cellular level of STIM1 and in a decreased
amount of STIM2 in MEF cells.
3.3. In HEK293 cells overexpressing PS1 with FAD mutations CCE is
attenuated, but level of STIM proteins is not changed
Attenuation of CCE is the most often observed alteration of Ca2+
homeostasis in cells bearing FAD PS1 mutations as reviewed in [4]
and [5]. To test, if FAD mutations in PS1 affect the expression of
STIM proteins, we examined HEK293 cell lines stably transfected
with wt PS1 or with different PS1 mutants, namely: S170F, I213F,
E318G, P117R and L226F. First, we analyzed CCE in these 6 celllines with the Fura-2 assay as described for MEF cells. We found
that overexpression of any of the analyzed PS1 FAD mutants
resulted in CCE attenuation in HEK293 cells in comparison with a
cell line transfected with wt PS1 (Fig. 3A,B, Supplementary Table
2.). In all cases of analyzed mutations except one (L226F), the
decrease of CCE was statistically signiﬁcant. These results conﬁrm
that attenuation of CCE is a characteristic feature of cells bearing
PS1 FAD mutations.
Knowing that CCE is altered in HEK293 cells overexpressing PS1
with FADmutations, we next measured the levels of STIM1 and STIM2
proteins in these cells. Analysis of immunoblots probed with speciﬁc
antibodies showed no statistically signiﬁcant differences in STIM
protein levels between cells overexpressing PS1 with FAD mutations
and cells transfected with wt PS1 (Fig. 3C and D). This demonstrates
that despite alterations of CCE by overexpression of PS1 FAD mutants,
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transfected cells.
3.4. In human B lymphocytes isolated from FAD patients with mutations
in PS1, CCE is attenuated and expression of STIM2 is decreased
Taking into consideration that overexpression of PS1 FAD mutants
on the background of endogenous wt PS1 did not reveal changes in
STIM protein's levels in HEK293 cells, we examined immortalized B
lymphocytes isolated from FAD patients with identiﬁed mutations in
endogenous PS1, namely: M139V, H163R, S170F, E318G, I213F and
P117R [27]. Human B lymphocytes were assayed with Fura-2 in the
same way as the MEF and HEK293 cells. Mean CCE was reduced in a
group of PS1 FAD B lymphocytes compared with controls (Fig. 4).
To investigate the putative link between attenuated CCE and
expression of STIM proteins in the population of human B lympho-
cytes bearing PS1 FAD mutations, we measured the levels of both
mRNA and protein of STIMs in these cells. The mRNA level for STIM1
protein was not affected in cells bearing PS1 FAD mutations (Fig. 5A).
Similarly, the densitometric analysis of immunoblots of protein
extracts obtained from B lymphocytes, probed with anti-STIM1
antibody, showed no difference in STIM1 protein levels between
two analyzed cell populations (Fig. 5B). However, a signiﬁcantly lower
level of STIM2 mRNA was detected in the group of cells with PS1 FAD
mutations compared to cells from healthy individuals (Fig. 5C).
Similarly, a decrease in the STIM2 protein level in cells bearing PS1
FAD mutations was observed (Fig. 5D and Supplementary Table 3.)
Cellular localization of STIM proteins was not altered in B cells with
PS1 FAD mutations (data not shown).
These results indicate that FAD mutations in PS1 lead to a decrease
of average STIM2 mRNA and protein levels in analyzed group of
human B cells. A decreased level of STIM2 and attenuated CCE
occurred in parallel in this group of cells, suggesting a possible link
between the level of this protein and alterations of Ca2+ stores
reﬁlling associated with PS1 FAD mutations.
4. Discussion
Disturbances of CCE as well as other alterations of Ca2+ home-
ostasis in AD had been reported both in neurons and in peripheral
cells [2,28,29]. PS1 and PS2, which are key proteins involved in AD
pathogenesis, had been shown to modulate CCE [12,30]. CCE
attenuation was demonstrated to inﬂuence proteolysis of APP and to
lead to increase of neurotoxic Aβ-42 generation in cells bearing PS1
FAD mutation [12]. Furthermore, STIM1 and STIM2 were recently
identiﬁed as key regulators of CCE in non-excitable cells [14,15]. We
have found that STIM1 and STIM2 interact with Orai1 upon
thapsigargin treatment to form puncta-like structures in neurons
[31]. Here, we showed that presenilins are involved in the regulation
of expression of STIM proteins.
We demonstrated that loss of PS1 or both presenilins results in
enhanced CCE, while PS1 FAD mutations exert the opposite effect on
Ca2+ inﬂux. Our results corroborate earlier reports on presenilins and
CCE [11–13,30] and thus further document the usefulness of ourFig. 6. Model of putative relationship between alterations in expression of STIM proteins
mutations in PS1 affect cellular levels of STIM proteins by a yet unknown mechanism, whiccellular models in studies on mechanisms of presenilin-related CCE
alterations. These data also show that the inhibition of CCE is one of
the biological activities of presenilins, as their loss causes CCE
enhancement in comparison to cells expressing wt PS1. Conversely,
expression of PS1 FAD mutants leads to the attenuation of CCE. This
indicates that FAD mutations in PS1 display a gain of function
phenotype in terms of CCE inhibition. However, the molecular
mechanism underlying CCE modulation mediated by presenilins has
not yet been clariﬁed.
We hypothesized that presenilins may affect the expression of
STIM1 and STIM2, and that presenilin-related disturbances in CCE,
observed in FAD, may result from altered STIM protein levels. We
found an increased protein level of STIM1 and a decreased protein
level of STIM2 in MEF DKO cells. These alterations correlated with
trends observed for Stim1 and Stim2mRNA levels. This shows that PS1
together with PS2 take part in the regulation of cellular levels of STIM
proteins and demonstrates that STIM1 and STIM2 are differently
affected by the loss of presenilins.
To get an insight into the putative contribution of alterations in
expression of STIM proteins to the pathogenesis of AD, we examined
cells bearing FAD mutations in PS1. Despite attenuated CCE, we found
no difference in STIM protein levels between HEK293 cells over-
expressing PS1 with FAD mutations and cell line transfected with wt
PS1. This may suggest that PS1 FAD dependent attenuation of CCE
results from other mechanisms than alteration of cellular levels of
STIM proteins. However, one cannot exclude that overexpression of
PS1 FAD mutants on the background of endogenous wt PS1 results in
subtle changes of STIM protein levels, which are however sufﬁcient to
cause CCE attenuation. This explanation seems to be reinforced by
results of experiments conducted on human B lymphocytes isolated
from patients bearing FAD mutations in endogenous PS1. We found
that STIM2 mRNA and protein level are down-regulated in the
population of B cells bearing PS1 FAD mutations. Decreased level of
STIM2 occurs in parallel to the attenuated CCE in the analyzed group of
B lymphocytes with PS1 FAD mutations.
FAD mutations in PS1 exert the opposite effect on CCE than do
presenilins knock-out. Moreover, the expression of STIM proteins is
differently affected by PS1 FADmutants than by the loss of presenilins.
We hypothesize that an elevated level of STIM1 in MEF DKO cell line
may mask the effect of a decrease in STIM2 and thus ﬁnally result in
CCE enhancement. This may be also the case for MEF PS1−/− cell
line, however increase of STIM1 protein level did not reach statistical
signiﬁcance in these cells. Such an explanation may be supported by
previously published observations that STIM1 is a more potent CCE
regulator than STIM2. Indeed, the expression of STIM1 in HeLa cells
facilitated higher CCE than the expression of the same concentration
of STIM2 protein [32]. Conversely, down-regulation of STIM2 with
speciﬁc siRNA caused CCE attenuation to a smaller degree than in
STIM1 depleted cells [14,32]. Such a masking effect of STIM1 protein is
not found in human B lymphocytes in which STIM1 is not elevated
above physiological level by FAD mutations in PS1. Hence, STIM2
down-regulation is sufﬁcient to attenuate CCE in these cells.
The observed trends of mRNA levels of STIM proteins may indicate
that presenilins exert their effects on STIM1 and STIM2 expressions attriggered by mutations in PS1 and dysregulation of CCE in cells of FAD patients. FAD
h may result in disturbances of CCE.
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may affect expression and stability of STIM proteins. The effect of
presenilins on the expression of STIM genes is likely indirect.
Presenilins, as an active constituents of the γ-secretase complex,
take part in the proteolytic liberation of amyloid protein intracellular
domain (AICD), reviewed in [33]. This domain was shown to play a
role in the regulation of transcription of several genes [34–36].
Therefore, its involvement in regulating the expression of STIM
proteins by presenilins should be taken into consideration. Presenilins
were also demonstrated to interact with several cellular signaling
cascades including phosphatidyloinositol-3 kinase/Akt, ERK1/ERK2
and Wnt, which possibly involve these pathways in the regulation of
transcription of STIM genes [37–39].
Our results conﬁrm previous observations that presenilins are
negative regulators of CCE and that FAD mutations in PS1 result in a
gain of function phenotype displayed as an attenuation of CCE. We
demonstrate here for the ﬁrst time that presenilins' loss affect the
mutual ratio of cellular levels of STIM proteins. Since presenilins are
known to be involved in multiple cellular processes (reviewed in [40])
themechanism of their inﬂuence on STIM1 and STIM2may be indirect
and sophisticated. No direct correlation between the extent of
alterations of CCE and STIM2 expression was found when B
lymphocyte cell lines with different PS1 FADmutations were analyzed
separately. However, group analysis revealed the decrease of both
mean mRNA and protein level of STIM2 occurring in parallel to the
attenuation of CCE in the population of B cells with mutations. This
suggests possible involvement of STIM proteins in SOCE alterations in
FAD. We propose a model according to which mutations in presenilins
alter cellular levels of STIM proteins (either by regulation of their
genes' expression or by inﬂuence on STIM proteins expression and
stability) and therefore may affect CCE in cells of FAD patients (Fig. 6).
Our observation opens a new perspective for research on CCE
alterations in FAD. Alterations of Ca2+ homeostasis have been
reported not only for neurons, but also for peripheral cells of AD
patients such as lymphocytes [13,41,42]. Nevertheless, further studies
on the role of STIM proteins in PS1 FAD dependent attenuation of CCE
in neurons are required to conﬁrm the putative role of STIM1 and
STIM2 in neurodegeneration observed in FAD.
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